COMP <GO>
MMSI vs JNJ // OPTIONS IMPLIED MOVE & PUT/CALL SKEW
Merit Medical Systems Inc. (NASDAQ) VS. Johnson & Johnson (NYSE) • 15-METRIC TALLY: MMSI 4
— JNJ 10
▲ OPTIONS IMPLIED MOVE & PUT/CALL SKEW LEADER: MMSI
LAST: $86.24 (-7.66%) • MKT CAP: $5.58B
options-implied-move
6.70%
LAST: $273.20 (-0.73%) • MKT CAP: $662.49B
options-implied-move
7.20%
15-METRIC INSTITUTIONAL SIDE-BY-SIDE SCORECARD (MMSI VS. JNJ)
EMERALD CELL = QUANTITATIVE EDGE
| INSTITUTIONAL METRIC | MMSI | JNJ | SPREAD (A - B) | ADVANTAGE | DEDICATED URL |
|---|---|---|---|---|---|
| Gross Profit Margin | 48.70% | 67.90% | -19.20 | JNJ | /gross-margins <GO> |
| Return on Invested Capital (ROIC) | 7.80% | 25.50% | -17.70 | JNJ | /roic <GO> |
| EV/EBITDA & P/E Valuation | 23.1x | 18.5x | +4.60 | JNJ | /valuation <GO> |
| Free Cash Flow Yield | 3.87% | 2.97% | +0.90 | MMSI | /fcf-yield <GO> |
| Operating Margin | 12.20% | 34.70% | -22.50 | JNJ | /operating-margins <GO> |
| Net Profit Margin | 8.50% | 28.50% | -20.00 | JNJ | /net-margins <GO> |
| Revenue Growth (YoY) | 11.80% | 6.00% | +5.80 | MMSI | /revenue-growth <GO> |
| Dividend Yield & FCF Payout Safety | 0.00% | 0.00% | 0.00 | TIE | /dividend-safety <GO> |
| Altman Z-Score & Debt/Equity | 4.62 | 5.59 | -0.97 | JNJ | /balance-sheet <GO> |
| Piotroski F-Score Quality | 9/9 | 8/9 | +1.00 | MMSI | /piotroski-score <GO> |
| Options Implied Move & Put/Call Skew ACTIVE | 6.70% | 7.20% | -0.50 | MMSI | /options-implied-move <GO> |
| RSI-14 & 200D SMA Momentum | 41.3 | 60.4 | -19.08 | JNJ | /rsi-technicals <GO> |
| 10Y Yield & FRED Macro Beta | 0.94 | 1.08 | -0.14 | JNJ | /macro-sensitivity <GO> |
| Forward P/E Multiple | 40.4x | 23.0x | +17.40 | JNJ | /forward-pe <GO> |
| Enterprise Scale & Market Cap | $5.58B | $662.49B | -$656.92B | JNJ | /market-cap <GO> |
5-YEAR HISTORICAL XBRL REVENUE & MARGIN TRAJECTORY SEC FORM 10-K FY
| FISCAL YEAR | MMSI REV | JNJ REV | MMSI GROSS % | JNJ GROSS % | MMSI FCF | JNJ FCF |
|---|---|---|---|---|---|---|
| FY 2025 | $1.52B | $94.19B | 48.7% | 67.9% | $215.7M | $19.70B |
| FY 2024 | $1.36B | $88.82B | 47.4% | 69.1% | $185.7M | $19.84B |
| FY 2023 | $1.26B | $85.16B | 44.0% | 44.0% | $88.6M | $18.96B |
FRED MACRO REGIME CORRELATION COMPARISON PEARSON r
MMSI // BETA 0.94
JNJ // BETA 1.08